Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 30.95 | N/A |
| PEG Ratio (TTM) | -2.24 | N/A |
| P/S Ratio (TTM) | 0.76 | N/A |
| P/B Ratio (TTM) | 5.95 | N/A |
| P/FCF Ratio (TTM) | 4.91 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.57% | N/A |
| ROE (TTM) | 16.82% | N/A |
| Net Profit Margin (TTM) | 2.46% | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 165.80% | -213.02% | N/A |
| Revenue | 4.34% | 24.28% | N/A |
| Net Income | 219.53% | -204.06% | N/A |
| Cash Flow | 73.35% | 9.13% | N/A |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.01 | N/A |
| Quick Ratio (TTM) | 1.01 | N/A |
| D/E Ratio (TTM) | 0.18 | N/A |
| Interest Coverage (TTM) | 2.46 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 0.83 | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |